Device-Related Infections in Critically Ill Patients. Part I: Prevention of Catheter-Related Bloodstream Infections

Journal of Chemotherapy

Volumn 15, Issue 5, 2003, Pages 419-427

  De Gaudio, A R ^a   Filippo, A D I ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Biofilm; Critically ill patients; Device; Intensive care unit; Nosocomial infection

Indexed keywords

BENZALKONIUM CHLORIDE; CHLORHEXIDINE; HEPARIN; MINOCYCLINE; NOVOBIOCIN; RIFAMPICIN; SILVER; SULFADIAZINE SILVER;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; CATHETER INFECTION; CRITICAL ILLNESS; HAND WASHING; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; REVIEW;

EID: 0142248190     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.5.419     Document Type: Review

References (43)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP, and the NNIS. Nosocomial infections in medical intensive care in USA. Crit Care Med 1999; 27: 887-92.
2. Konig C, Schwank S, Blaser J. Factors compromising antibiotic activity against biofilms of Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis 2001; 20: 20-6
3. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 9: 881-90.
4. Shing-Naz N, Sprague BM, Patel KM, Pollack MM. Risk assessment and standardized nosocomial infection rate in critically ill children. Crit Care Med 2000; 28: 2069-74.
5. Calil R, Marba ST, von Nowakonski A, Tresoldi AT. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 2001; 29: 133-8.
6. Lemmen SW, Zolldann D, Gastmeier P, Lutticken R. Implementing and evaluating a rotating surveillance system and infection control guidelines in 4 intensive care units. Am J Infect Control 2001; 29: 89-93.
7. Pearson ML Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24: 262-77.
8. Larson EL, Aiello AE, Bastyr J, et al. Assessment of two hand hygiene regimens for intensive care unit personnel. Crit Care Med 2001; 29: 944-51.
9. Girou E, Loyeau S, Legrand P, Oppein F, Brun-Buisson C. Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomised clinical trial. Br Med J 2002; 325: 362-5.
10. Hirschmann H, Fux L, Podusel J, et al. The influence of hand hygiene prior to insertion of peripheral venous catheters on the frequency of complications. J Hosp Infect 2001; 49: 199-203.
11. Maas A, Flament P, Pardou A, Deplano A, Dramaix M, Struelens MJ. Central venous catheter-related bacteraemia in critically ill neonates: risk factors and impact of a prevention programme. J Hosp Infect 1998; 40: 211-24.
12. Slota M, Green M, Farley A, Janosky J, Carcillo J. The role of gown and glove isolation and strict hand washing in the reduction of nosocomial infection in children with solid organ transplantation. Crit Care Med 2001; 29: 405-12.
13. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomised trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31: 1001-7.
14. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136: 792-801.
15. Little K, Palmer D. Central line exit sites: which dressing? Nurs Stand 1998; 12: 42-44.
16. Nikoletti S, Leslie G, Gandossi S, Coombs G, Wilson R. A prospective, randomised, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am J Infect Control 1999; 27: 488-96.
17. O'Leary M and Bihari D. Central venous catheters. Time for a change? Br Med J 1998; 316: 1918-9.
18. Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997; 25: 1417-24.
19. Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 2002; 30 (12): 2632-5.
20. Mahieu LM, De Dooy JJ, Lenaerts AE, Ieven MM, De Muynck AO. Catheter manipulations and the risk of catheterassociated bloodstream infection in neonatal intensive care unit patients. J Hosp Infect. 2001; 48: 20-6.
21. Fraenkel DJ, Rickard C, Lipman J. Can we achieve consensus on central venous catheter-related infections? Anaesth Intensive Care 2000; 28: 475-90.
22. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of grampositive infections in neutropenic patients with indwelling central venous catheters: a randomised, controlled study. Support Care Cancer 1997; 5: 485-8.
23. Raad II, Hachem RY, Abi-Said D, et al. A prospective crossover randomised trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer 1998; 82: 403-11.
24. Ma TY, Yoshinaka R, Banaag A, Johnson B, Davis S, Berman SM. Total parenteral nutrition via multilumen catheters does not increase the risk of catheter-related sepsis: a randomised, prospective study. Clin Infect Dis 1998; 27: 500-3.
25. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402.
26. Bach A, Eberhardt H, Frick A, Schmidt H, Bottiger BW, Martin E. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 1999; 27: 515-21.
27. Boswald M, Lugauer S, Regenfus A, et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999; 27 (Suppl): S56-60.
28. Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002; 50(3): 202-6.
29. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomised, controlled trial. Ann Intern Med 1997; 127: 257-66.
30. George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 1997; 14: 428-31.
31. Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomised trial of an antibiotic-and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997; 132: 1348-51.
32. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteraemia. Arch Intern Med 1998; 158: 81-7.
33. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999; 115: 1632-40.
34. Hannan M, Juste RN, Umasanker S, et al. Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 1999; 54: 868-72.
35. Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000; 38: 1-5.
36. Jaeger K, Osthaus A, Heine J, et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemotherapy 2001; 47: 50-5.
37. Ranucci M, Isgrò G, Giomarelli PP, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003; 31(1): 52-59.
38. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomised, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127: 267-74.
39. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340: 1-8.
40. Bach A. antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1761.
41. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 2000; 26: 967-72.
42. Timsit JF, Bruneel F, Cheval C, et al. Use of tunnelled femoral catheters to prevent catheter-related infection. A randomised, controlled trial. Ann Intern Med 1999; 130: 729-3.
43. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterisation in critically ill patients: a randomised controlled trial. JAMA 2001; 286: 700-7.